Cefoperazone is NOT recommended for typhoid fever or urinary tract infections
Cefoperazone is not included in any current evidence-based guidelines for treating either typhoid fever or urinary tract infections, and you should use guideline-recommended alternatives instead.
Critical Clarification
The question asks about "cefeperazone" (cefoperazone), but the evidence provided discusses cefepime, which is a completely different antibiotic. These are distinct fourth-generation cephalosporins with different spectrums of activity and clinical indications.
For Urinary Tract Infections
Recommended Agents (NOT Cefoperazone)
For uncomplicated pyelonephritis requiring IV therapy, the 2024 European Association of Urology guidelines recommend 1:
- First-line options: Fluoroquinolones (ciprofloxacin 400 mg IV twice daily, levofloxacin 750 mg daily) OR extended-spectrum cephalosporins (ceftriaxone 1-2 g daily, cefotaxime 2 g three times daily, cefepime 1-2 g twice daily)
- Aminoglycosides with or without ampicillin
For complicated UTIs with sepsis, the 2026 IDSA guidelines specify 2:
- Third- or fourth-generation cephalosporins (cefepime is listed, NOT cefoperazone)
- Carbapenems
- Piperacillin-tazobactam
- Fluoroquinolones
Why Cefepime Works (But Cefoperazone Doesn't Appear in Guidelines)
Cefepime has FDA approval for complicated and uncomplicated UTIs including pyelonephritis 3. Clinical trials demonstrate 90-95% efficacy for serious UTIs in both adults and children 4, 5, 6. A 2024 study showed cefepime superior to meropenem for complicated UTI (70.6% vs 58.0% composite success) 7.
Important caveat: For ESBL-producing organisms, cefepime should only be used when MIC ≤1 µg/mL; at MIC = 2 µg/mL, carbapenems are more effective 8, 9.
For Typhoid Fever
Recommended Agents (NOT Cefoperazone)
The 2015 WHO guidelines for typhoid in children recommend 10:
- First-line: Ciprofloxacin 15 mg/kg twice daily orally for 7-10 days
- Second-line: Ceftriaxone 80 mg/kg IV daily for 5-7 days OR azithromycin 20 mg/kg daily for 5-7 days
Cefotaxime (a different third-generation cephalosporin) has documented efficacy in enteric fever 11, but cefoperazone is not mentioned in any typhoid treatment guidelines.
Critical Safety Concern with Cefepime
While cefepime is guideline-recommended for UTIs, it carries significant neurotoxicity risk, particularly in elderly patients or those with renal impairment. Dose adjustment is mandatory when creatinine clearance ≤60 mL/min 3. Cefepime-induced encephalopathy can occur within days, presenting with confusion, myoclonus, seizures, and altered mental status 12. This typically resolves 48 hours after discontinuation.
Bottom Line Algorithm
For UTI:
- If uncomplicated pyelonephritis → Use ceftriaxone 1-2 g IV daily OR fluoroquinolone (if local resistance <10%)
- If complicated UTI without sepsis → Cefepime 1-2 g IV twice daily is acceptable
- If ESBL suspected → Use carbapenem, NOT cefepime
- Never use cefoperazone - it lacks guideline support
For Typhoid:
- First choice → Ciprofloxacin oral
- Severe cases → Ceftriaxone IV (NOT cefoperazone)
- Alternative → Azithromycin
Cefoperazone has no established role in either condition based on current evidence.